ANI Pharmaceuticals Inc (ANIP)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Arthur S. Przybyl
Employees:
299
210 MAIN STREET WEST, BAUDETTE, MN 56623
2186343500

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Data derived from most recent annual or quarterly report
Market Cap 720.389 Million Shares Outstanding16.742 Million Avg 30-day Volume 132.354 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.37
Price to Revenue2.0368 Debt to Equity0.9004 EBITDA40.471 Million
Price to Book Value2.1319 Operating Margin-2.4055 Enterprise Value592.644 Million
Current Ratio2.209 EPS Growth-8.846 Quick Ratio1.413
1 Yr BETA 1.2515 52-week High/Low 60.23 / 26.1 Profit Margin-7.2464
Operating Cash Flow Growth3.5552 Altman Z-Score1.6617 Free Cash Flow to Firm 15.069 Million
View SEC Filings from ANIP instead.

View recent insider trading info

Funds Holding ANIP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANIP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

6.6 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THOMA JEANNE

17,785 2021-12-20 2

PERA ANTONIO R

19,713 2021-12-07 2

HAUGHEY THOMAS

30,202 2021-12-06 2

SHANMUGAM MUTHUSAMY HEAD OF R&D, COO-NOVITIUM OPS

0 2021-11-19 2

GASSERT CHAD SVP - CORP. DEV. & STRATEGY

383,226 2021-11-19 2

LALWANI NIKHIL PRESIDENT & CEO

162,426 2021-09-08 2

MARKEN JAMES G. SVP OPS & PROD DEV

114,321 2021-04-12 4

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

112,500 2021-04-12 4

SCHREPFER ROBERT W SVP - NEW BUS DEV & SPEC SALES

No longer subject to file 2021-03-29 1

NASH DAVID

21,647 2021-03-23 1

BROWN ROBERT E. JR

38,972 2021-03-23 1

WALSH PATRICK D

48,388 2021-03-23 2

GUTWERG ORI SVP, GENERICS

0 2021-02-15 2

MUTZ CHRISTOPHER CHIEF COMMERCIAL OFFICER

0 2021-02-15 2

PRZYBYL ARTHUR PRESIDENT AND CEO

  • Officer
  • Director
190,309 2020-04-06 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

BROWN ROBERT E. JR

  • Director
  • 10% Owner
2,281,283 2019-08-19 0

PENN THOMAS A.

  • Director
14,301 2019-03-28 0

MARSHBANKS TRACY

  • Director
349,934 2018-05-14 0

HOLUBOW FRED

  • Director
14,811 2018-03-20 0

RAYNOR DANIEL

  • Director
289,003 2018-03-15 0

LANKAU PETER A

  • Director
2,500 2016-04-07 0

ARNOLD CHARLOTTE C. VICE PRESIDENT AND CFO

  • Officer
54,298 2016-04-07 0

MANGANO ROSS J

  • Director
26,914 2014-09-15 0

JAMNICK ROBERT J. VP, QUALITY & PRODUCT DEVELOP.

  • Officer
48,118 2014-05-22 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

  • 10% Owner
16,918,469 2013-06-19 0

BROWN ROBERT E. JR

PENN THOMAS A.

  • Director
  • 10% Owner
16,918,469 2013-06-19 0

SHERWIN STEPHEN A

  • Director
86,760 2012-03-30 0

SULLIVAN LOUIS W

  • Director
47,898 2012-03-30 0

POTTS JOHN T JR

  • Director
5,581 2012-03-30 0

ROSENOW EDWARD C III

  • Director
20,540 2012-03-30 0

SIMES STEPHEN M VICE CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
202,267 2012-01-25 0

DONENBERG PHILIP B SR VP OF FINANCE, CFO, SECY

  • Officer
44,322 2012-01-25 0

SNABES MICHAEL C SR. VP OF MEDICAL AFFAIRS

  • Officer
0 2012-01-25 0

KJAER PETER

  • Director
34,425 2010-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

THOMA JEANNE

2021-12-22 20:06:48 -0500 2021-12-20 P 1,072 $46.47 a 17,785 direct -2.1807 -9.4695 0.0 1 -9.4695 6

PERA ANTONIO R

2021-12-09 16:31:36 -0500 2021-12-07 P 3,000 $42.26 a 19,713 direct -0.6404 7.1363 7.1821 4 -0.6404 2

HAUGHEY THOMAS

2021-12-07 16:17:43 -0500 2021-12-06 P 2,500 $39.38 a 30,202 direct -1.1473 7.5264 7.5264 6 -1.1473 2

GASSERT CHAD SVP - CORP. DEV. & STRATEGY held by chali properties llc

2021-11-23 16:44:43 -0500 2021-11-19 A 383,226 a 383,226 indirect -2.9979 -2.4506 4.3778 21.104 21 -5.9005 7

SHANMUGAM MUTHUSAMY HEAD OF R&D, COO-NOVITIUM OPS held by esjay llc

2021-11-23 16:46:30 -0500 2021-11-19 A 1,332,620 a 1,332,620 indirect -2.9979 -2.4506 4.3778 21.104 21 -5.9005 7

SHANMUGAM MUTHUSAMY HEAD OF R&D, COO-NOVITIUM OPS

2021-11-23 16:46:30 -0500 2021-11-19 A 13,460 a 13,460 direct -2.9979 -2.4506 4.3778 21.104 21 -5.9005 7

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ANI PHARMACEUTICALS INC ANIP 2022-01-14 22:15:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 21:45:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 21:15:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 20:45:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 20:15:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 19:45:03 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 19:15:04 UTC -0.2415 0.3115 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 18:45:04 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 18:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 17:45:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 17:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 16:45:04 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 16:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 15:45:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 15:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 14:45:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 14:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 13:45:02 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 13:15:03 UTC -0.2218 0.2918 550000
ANI PHARMACEUTICALS INC ANIP 2022-01-14 12:45:03 UTC -0.2218 0.2918 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund ANIP -66.0 shares, $-2688.84 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ANIP -42.0 shares, $-1711.08 2020-03-31 N-PORT

Elevate your investments